Organ Sparing Surgery in Testicular Cancer
| Autor: | Whitehurst L; Department of Urology, University Hospitals Sussex, Princess Royal Hospital, Haywards Heath, UK, Chetwood A; Department of Urology, Frimley Park Hospital, Frimley Park NHS Trust, Camberley, UK |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | 2022 Sep 12. |
| DOI: | 10.36255/exon-publications-urologic-cancers |
| Abstrakt: | Testicular cancer is the most common cancer amongst young adult men. The gold standard of treatment for a testicular tumor is a radical orchidectomy, where the testis and spermatic cord are removed, however up to 50% of testicular pathology is benign and these patients are being overtreated. Organ-sparing surgery can be an alternative for patients with small, indeterminate testicular lesions and normal tumor markers. It can also be considered as an option for patients with tumors in a solitary testis, or where bilateral tumors are present. Combined with frozen section examination, tumors can safely be removed, and any residual disease identified intraoperatively. Organ-sparing surgery has safe oncological outcomes, with low recurrence rates on follow up data. It also provides a beneficial effect on the fertility and the hormonal profile of these patients. As these patients have a >95% survival rate, providing a high quality of life should be prioritized. (Copyright: The Authors.; The authors confirm that the materials included in this chapter do not violate copyright laws. Where relevant, appropriate permissions have been obtained from the original copyright holder(s), and all original sources have been appropriately acknowledged or referenced.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|